RUXMEOR

Serial Number 86743948
606

Registration Progress

Application Filed
Sep 1, 2015
Under Examination
Mar 22, 2016
Approved for Publication
Jan 26, 2016
Published for Opposition
Jan 26, 2016
Registered

Trademark Image

RUXMEOR

Basic Information

Serial Number
86743948
Filing Date
September 1, 2015
Published for Opposition
January 26, 2016
Abandonment Date
April 22, 2019
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Apr 22, 2019
Classes
005

Rights Holder

Pfizer Inc.

03
Address
235 East 42nd Street
New York, NY 10017

Ownership History

Pfizer Inc.

Original Applicant
03
New York, NY

Pfizer Inc.

Owner at Publication
03
New York, NY

Legal Representation

Attorney
Katrina Edge

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

31 events
Date Code Type Description Documents
Apr 22, 2019 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Apr 22, 2019 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Sep 27, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 26, 2018 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Sep 26, 2018 EX5G S SOU EXTENSION 5 GRANTED Loading...
Sep 18, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 18, 2018 EXT5 S SOU EXTENSION 5 FILED Loading...
Mar 14, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 12, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 12, 2018 EXT4 S SOU EXTENSION 4 FILED Loading...
Mar 12, 2018 EX4G S SOU EXTENSION 4 GRANTED Loading...
Sep 20, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 18, 2017 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 18, 2017 EXT3 S SOU EXTENSION 3 FILED Loading...
Sep 18, 2017 EX3G S SOU EXTENSION 3 GRANTED Loading...
Mar 14, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 10, 2017 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 10, 2017 EXT2 S SOU EXTENSION 2 FILED Loading...
Mar 10, 2017 EX2G S SOU EXTENSION 2 GRANTED Loading...
Aug 27, 2016 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 25, 2016 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 25, 2016 EXT1 S SOU EXTENSION 1 FILED Loading...
Aug 25, 2016 EX1G S SOU EXTENSION 1 GRANTED Loading...
Mar 22, 2016 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jan 26, 2016 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 26, 2016 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 6, 2016 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 15, 2015 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 14, 2015 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 4, 2015 NWAP I NEW APPLICATION ENTERED Loading...
Sep 4, 2015 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005